Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT
Related Experiment Video
Updated: Jun 10, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Ines Valenta1, Alessandra Quercioli, Gabriella Vincenti
1Department of Internal Medicine, Cardiovascular Center, Nuclear Cardiology, University Hospital of Geneva, Geneva, Switzerland.
Insights
Epicardial structural disease and impaired microvascular function significantly impact longitudinal myocardial blood flow (MBF) differences in cardiovascular risk patients. PET/CT imaging reveals these abnormalities, aiding in risk assessment.
Area of Science:
- Cardiology
- Nuclear Medicine
- Radiology
Background:
- Cardiovascular risk individuals may exhibit altered myocardial blood flow (MBF) patterns.
- Epicardial disease's influence on longitudinal MBF and its response to hyperemia requires investigation.
Purpose of the Study:
- To assess if epicardial structural disease affects longitudinal MBF decrease during hyperemia in cardiovascular risk individuals.
- To determine the dependency of this effect on flow increase.
Main Methods:
- Myocardial blood flow (MBF) was measured using (13)N-ammonia and PET/CT in 54 cardiovascular risk individuals and 26 controls.
- Rest and dipyridamole-stimulated MBF were assessed, alongside computed tomography coronary angiography (CTA).
Main Results:
- A more pronounced longitudinal MBF difference was observed in at-risk individuals compared to controls.
- This difference was influenced by both epicardial disease (CTA findings) and microvascular function (mid-LV hyperemic MBF increase).
- Log-CCS and mid-LV hyperemic MBF increase independently predicted the longitudinal MBF difference.
Conclusions:
- Epicardial structural disease is a key determinant of abnormal longitudinal MBF differences.
- Microvascular function also plays a crucial role in these flow abnormalities.
- PET/CT imaging effectively identifies these determinants of altered MBF.
Background:
The aim of this study was to determine whether epicardial structural disease may affect the manifestation of a longitudinal decrease in myocardial blood flow (MBF) or MBF difference during hyperemia in cardiovascular risk individuals, and its dependency on the flow increase.
Methods And Results:
In 54 cardiovascular risk individuals (at risk) and in 26 healthy controls, MBF was measured with (13)N-ammonia and PET/CT in mL/g/min at rest and during dipyridamole stimulation. Computed tomography coronary angiography (CTA) was performed using a 64-slice CT of a PET/CT system. Absolute MBFs during dipyridamole stimulation were mildly lower in the mid-distal than in the mid-LV myocardium in controls (2.20 ± .51 vs 2.29 ± .51, P < .0001), while it was more pronounced in at risk with normal and abnormal CTA (1.56 ± .42 vs 1.91 ± .46 and 1.18 ± .34 vs 1.51 ± .40 mL/g/min, respectively, P < .0001), resulting in a longitudinal MBF difference that was highest in at risk with normal CTA, intermediate in at risk abnormal CTA, and lowest in controls (.35 ± .16 and .22 ± .09 vs .09 ± .04 mL/g/min, respectively, P < .0001). On multivariate analysis, log-CCS and mid-LV hyperemic MBF increase, indicative of microvascular function, were independent predictors of the observed longitudinal MBF difference (P ≤ .004 by ANOVA).
Conclusions:
Epicardial structural disease and microvascular function are important determinants of an abnormal longitudinal MBF difference as determined with PET/CT.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...